Carcinoma lobulillar infiltrante de la mama : tipos histológicos y riesgo de metástasis en 126 casos

Zanetto, Ulises; Maturi, Horacio V; Peralta, Carlos A; Peralta, Osvaldo C; Tasca, Ana M; Rivadulla, María C; Torres, Néstor; De Schant, Fermín E. H.
CM publ. méd ; 11(1): 3-6, oct. 1998.
Artículo en Español | LILACS | ID: lil-248718

Documentos relacionados

  1. Genetic predisposition to male breast cancer in Poland.
  2. Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit.
  3. Germline Genetic Testing Among Women ≤ 45 Years of Age with Ductal Carcinoma In Situ Versus Invasive Breast Cancer in a Large Integrated Health Care System.
  4. The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population.
  5. Risk factors of breast cancer among patients in a tertiary care hospitals in Afghanistan: a case control study.
  6. Ki67 as Proliferative Marker in Patients with Early Breast Cancer and Its Association with Clinicopathological Factors.
  7. Healthy lifestyle index and the risk of ductal carcinoma in situ of the breast in the Women's Health Initiative.
  8. Circulating levels of biomarkers and risk of ductal carcinoma in situ of the breast in the UK Biobank study.
  9. Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.
  10. Triple negative breast cancer: A clinico-epidemiological and histopronostic study of 90 cases.